Patient-tailored, effective and safe combinatorial therapies

Akronym

PatientTherapy

Bidragets beskrivning

Combination therapies are often needed to improve treatment outcomes of cancer patients. However, we lack systematic approaches to identify maximally effective and safe combinatorial treatments for individual patients. This project will test a predictive platform that identifies patient-tailored treatment options in terms of its technical feasibility and clinical relevance (improved efficacy and reduced adverse effects). A pilot study will evaluate the platform's predictions against clinical outcomes of leukemia patients treated with combination therapies. A close collaboration with clinicians, computational and cancer researchers make it possible to implement a widely applicable therapy prediction platform and to provide ground-breaking impacts to patients and society. The project is expected to lead to increased treatment efficacy, and reduced use of ineffective therapies and adverse effects, which currently lead to enormous individual suffering and economic burden for the society.
Visa mer

Startår

2026

Slutår

2027

Beviljade finansiering

Tero Aittokallio Orcid -palvelun logo
280 166 €


Rollen i Finlands Akademis konsortium

Ledare

Övriga parter i konsortiet

Partner
Aalto-universitetet (373494)
169 123 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprojekt med särskild inriktning

Beslutfattare

Suomen akatemian muu päättäjä
03.11.2025

Övriga uppgifter

Finansieringsbeslutets nummer

373493

Vetenskapsområden

Data- och informationsvetenskap

Forskningsområden

Laskennallinen tiede

Identifierade teman

cancer